Skip to main content

Table 3 Disease characteristics

From: A pilot study to assess the feasibility of evaluation of markers of response to chemotherapy at one day & 21 days after first cycle of chemotherapy in carcinoma of breast: a prospective non-randomized observational study

Parameter

N

Percent

Stage of disease at presentation

  

II B

4

13.3

III A

7

23.3

III B

5

16.7

III C

4

13.3

IV

10

33.3

Histological type

  

Infiltrating ductal carcinoma (IDC)

27

90.0

Infiltrating lobular carcinoma (ILC)

2

6.7

Combined ILC & IDC

1

3.3

Grade of tumor

  

Low grade

4

13.3

Intermediate grade

14

46.7

High grade

12

40.0

Miller-Payne response #

  

Poor

Grade I (no or <10% response)

5

16.7

pathological

Grade II (10–30% response)

4

13.3

response (PPR)

Grade III (30–90% response)

8

26.6

Good pathological

Grade IV (>90% response)

4

13.3

response (GPR)

Grade V (complete response or few isolated tumor cell islands remaining)

5

16.7

  1. #: Miller Payne response could not be assessed in 4 patients who did not undergo surgery